This Fund is Soft Closed and is not currently available to new investors

Biotechnology Fund

Equity investors in medical innovation

Launch Date31.10.2013
Base CurrencyUS$
DenominationsUS$ / GBP / EUR
DomicileDublin, Ireland
IndexNASDAQ Biotechnology
US$43.11
US$ Class I Dist
NAV per share 10.06.2021
£1,020mAUM

AUM 28.05.2021

Holdings
72.44% Active Share
As at 28.05.2021